Mirae Asset Healthcare Fund
Sectoral · Direct Growth Very High Risk
₹50.8750
NAV on 28-Oct-2026
Showing the Direct plan. The Regular plan you picked has the same portfolio but a higher expense ratio, so its NAV and returns are lower.
Fund size (AUM)
₹3,494 Cr
Expense ratio
0.62%
Since inception (CAGR)
+21.57%
Minimum SIP · lump sum
₹99 · ₹5,000
Returns
absolute up to 1Y, annualised beyond| 1M | 3M | 6M | 1Y | 3Y | 5Y | 10Y | |
|---|---|---|---|---|---|---|---|
| This fund | -2.10% | +0.17% | +12.38% | +16.91% | +23.34% | +16.32% | — |
| Category average | — | -4.89% | +7.29% | +6.47% | +20.21% | +14.60% | — |
About
| Fund house | Mirae Asset Mutual Fund |
| Fund managers | Neelesh Surana |
| Benchmark | BSE Healthcare Total Return Index |
| Launched | 02-Jul-2018 |
| ISIN | INF769K01ED6 |
| Exit load | Exit load of 1% if redeemed within 1 Month. |
Risk
| Standard deviation | 16.36 |
| Sharpe ratio | 0.94 |
| Sortino ratio | 1.58 |
| Alpha | 0.76 |
| Beta | 0.97 |
Top holdings
32 in total| Holding | Sector | Value | % of fund |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | ₹355 Cr | 10.15% |
| Divi's Laboratories Ltd | Healthcare | ₹342 Cr | 9.79% |
| Torrent Pharmaceuticals Ltd | Healthcare | ₹238 Cr | 6.80% |
| Apollo Hospitals Enterprise Ltd | Healthcare | ₹196 Cr | 5.62% |
| Laurus Labs Ltd | Healthcare | ₹193 Cr | 5.51% |
| Dr. Reddy's Laboratories Ltd | Healthcare | ₹169 Cr | 4.84% |
| Glenmark Pharmaceuticals Ltd | Healthcare | ₹167 Cr | 4.78% |
| Aurobindo Pharma Ltd | Healthcare | ₹132 Cr | 3.78% |
| Alkem Laboratories Ltd | Healthcare | ₹131 Cr | 3.76% |
| Ipca Laboratories Ltd | Healthcare | ₹118 Cr | 3.39% |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | ₹118 Cr | 3.39% |
| Aster DM Healthcare Ltd | Healthcare | ₹116 Cr | 3.32% |
| Sai Life Sciences Ltd. | Healthcare | ₹113 Cr | 3.23% |
| Onesource Specialty Pharma Ltd | Healthcare | ₹105 Cr | 3.01% |
| Fortis Healthcare Ltd | Healthcare | ₹103 Cr | 2.94% |
| Dr. Lal Pathlabs Ltd | Healthcare | ₹101 Cr | 2.90% |
| Gland Pharma Ltd | Healthcare | ₹94 Cr | 2.69% |
| Cipla Ltd | Healthcare | ₹92 Cr | 2.63% |
| Eris Lifesciences Ltd | Healthcare | ₹83 Cr | 2.39% |
| Max Healthcare Institute Ltd | Healthcare | ₹82 Cr | 2.35% |
Fetched 29 Oct, 17:38 IST. Past returns don't predict future returns. Source: Indian Stock API.